Today, Thursday, March 13, the Secretary of State for Health of the Government of Spain, Javier Padilla, visited HIPRA's headquarters, where he met with the company's management and toured the R&D and production facilities. During the visit, he had the opportunity to see first-hand the company's progress and commitments in the field of biotechnology applied to health.

During the meeting, the strategic role of biotechnology in the current context, marked by continuous challenges in the health sector, was highlighted. Five years ago, the pandemic tested the sector's capacity for innovation and response, and HIPRA took on the challenge with determination, reaffirming the importance of research and the production of biotechnological solutions.

Currently, this commitment remains the driving force behind HIPRA, pushing the company to develop cutting-edge solutions in both human and animal health, working closely with institutions and organizations to contribute to a more prepared and resilient Europe and world.

HIPRA sincerely appreciates the visit of Javier Padilla and his support for research and innovation in health, a key area for the future of healthcare in Spain and Europe.